Irving, Texas (PRWEB) February 11, 2016
Thermi™, a world leader in thermistor-regulated energy solutions for plastic surgery, dermatology and women’s health, is pleased to announce the promotions of Allison Kelly to executive vice president of the company’s new North American Practice Development Partners sales team, Steve Catone to executive vice president of North American capital sales, and Wendy Oseas to vice president of global marketing. Thermi™ was recently acquired by Almirall, a global company based in Barcelona, Spain.
Ms. Kelly and Mr. Catone joined Thermi™ in 2014 serving as regional vice presidents of sales. Together they bring more than three decades of experience in sales and business development in the medical and aesthetic medical industry. Kelly and Catone created teams that helped contribute to unprecedented triple digit revenue growth in both 2014 and 2015.
“Ms. Kelly will head a new North American sales division of 20 Practice Development Partner representatives to grow consumables revenue and offer a higher level of customer support for customers,” said company president, Kevin O’Brien. “This will further strengthen the company’s position as the industry leader in customer service. Mr. Catone will expand the existing North American capital sales team to 33 representatives in four sales regions. Catone’s proven track record for successfully leading elite sales organizations is well suited to head Thermi’s™ North American capital sales efforts as we continue our mission to engage physicians with energy based advancements in aesthetic medicine and women’s health.”
Ms. Oseas brings more than 18 years’ medical device experience and joined Thermi™ in June 2015 as vice president of aesthetic marketing. In her short term with Thermi™ Oseas and her team led the rebranding of the company and expanded educational programs with some of the world’s most influential key opinion leaders in aesthetics and women’s health.
“It is with extreme pleasure that Wendy Oseas is being promoted to vice president of global marketing. Since joining Thermi™ Wendy has made numerous positive changes within the company and is a valuable asset for both domestic and international growth we are expecting in 2016,” continued O’Brien.
Thermi™ is a leading manufacturer of thermistor-regulated solutions for the aesthetic and gynecologic markets. With three platforms: ThermiRF®, ThermiVa® and Thermi250®, aesthetic physician’s gynecologists offer a wide array of solutions for patients using “the science of heat” where temperature is the clinical endpoint. The company’s products are distributed worldwide.
For more information please visit: http://www.thermi.com.
Almirall is a global company based in Barcelona dedicated to providing valuable medicines through its R&D, agreements and alliances. Our work covers the whole of the drug value chain. A consolidated growth allows us to devote our talent and efforts towards specialty areas and particularly to further grow as a leading Dermatology player. Our size enables us to be agile and flexible so that we can accomplish the purpose of taking our innovative products wherever they are needed.
Founded in 1943, Almirall is listed on the Spanish Stock Exchange (ticker: ALM) and it has become a source of value creation for society due to its vision and the commitment of its long-standing major shareholders. In 2014, its revenues totaled 1,407 million euros and, with more than 2,100 employees, it has gradually built up a trusted presence across Europe, as well as in the US and Mexico.
For more information, please visit http://www.almirall.com.
Editor's Note: For more information about Thermi™ and to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or pam(at)trentandcompany(dot)com.